Highwise Health
U.S.

Fertility Sector Investments Shifted Toward New Technology

As families delay childbirth, investors are moving from clinic consolidation to artificial intelligence tools.

Updated on Sept. 21, 2026 in Pregnancy

Bold vector editorial illustration of a microscopic structure in a petri dish, representing modern fertility diagnostic technology.
Investors are shifting capital toward AI-powered diagnostics and embryo selection tools as fertility care undergoes a rapid technological evolution. AI Illustration. Upload story photo >

Live Poll

Should fertility benefits be a standard expectation for employee compensation packages?

A recent market analysis by PwC shows that investment in fertility care has pivoted from acquiring clinics toward funding precision diagnostics. This shift aims to improve outcomes for a growing number of individuals navigating later family-building timelines.

Why it matters

As the average age of first-time U.S. mothers has risen to 27.5 years, employers and policymakers are increasingly treating fertility coverage as a critical benefit. These market changes influence how patients access care and the technologies used to support implantation success.

Deep learning time-lapse models reached 62.5% accuracy in implantation prediction compared to the 51.9% baseline accuracy of human embryologists. These figures represent current technical performance in laboratory settings rather than final clinical birth outcomes.

The players

PwC

A global professional services network that publishes research on market trends, including the reproductive health sector.

The details

Industry capital is moving toward precision tools like time-lapse imaging and deep learning algorithms that assist in embryo selection. By analyzing developmental milestones at a microscopic level, these AI models provide more consistent data than manual review alone. Simultaneously, broader access is expanding through insurance mandates in 25 states and Washington, D.C., and increasing corporate benefits.

Timeline

  1. The average age of first-time U.S. mothers reached 27.5 years by 2023.

  2. Private equity firms deployed $14 billion into fertility clinics from 2020 to 2025.

  3. Elective egg freezing cycles in the U.S. grew nearly fourfold between 2014 and 2021.

  4. Insurance coverage mandates were enacted in 25 states and Washington, D.C. as of March 2026.

  5. The fertility market is projected to reach $45 billion by 2030.

Health Landscape

This pivot reflects a broader maturation of the fertility sector as it moves beyond simple clinic scale. It follows the pattern established by the historical consolidation of independent medical practices into regional platforms, now transitioning toward AI-driven laboratory tools.

If you are exploring fertility options, ask your clinic what technologies they use to assess embryo viability. It is worth discussing with your doctor how local coverage mandates or employer-sponsored benefits might apply to your specific care plan.

The takeaway

The fertility industry is currently prioritizing technological precision alongside traditional clinical scaling. Track your employer's evolving benefit offerings and consult a specialist to understand how new diagnostics might factor into your care.

Further reading

For more information on the latest reproductive health research, visit our Pregnancy section.

Source note: This article includes information reported by Hitconsultant.

Live Poll

Should fertility benefits be a standard expectation for employee compensation packages?